Medication info
Richstar Tablet 40/10 Milligrams

Richstar Tablet 40/10 Milligrams

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Poonglim Pharm. Co., Ltd.
Appearance
It is a white and light gray biconvex oval double tablet.
Packaging
30 tablets (10 tablets/PTP) × 3
Approval status
Active

MFDS item code 201700543 · Approved 2017.01.31

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
This medicine is not recommended for pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Poonglim Pharm. Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential Hypertension
View approved original text

This medicine is used for patients with essential hypertension for whom blood pressure control is insufficient with monotherapy with either amlodipine or telmisartan. It effectively lowers blood pressure to reduce the risk of cardiovascular diseases and helps maintain a healthy blood pressure status.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

This medicine is not recommended for pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This medication can cause serious risks to the fetus during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. Patients with hypersensitivity to this drug, certain liver disorders, obstructive biliary disease, severe hypotension, or serious heart conditions should not use it. Patients with poor liver function, heart valve disease, or renal issues should exercise caution when using this drug, and dosage adjustments may be necessary. As this drug has a blood pressure-lowering effect, it may cause hypotension; therefore, patients in a state of dehydration should be particularly cautious, and if symptoms of hypotension occur, they should seek appropriate treatment immediately. Patients at risk of hyperkalemia should regularly monitor potassium levels through blood tests, and caution is necessary when using medications that contain a high amount of potassium together with this drug. Patients with impaired kidney function should regularly check and monitor kidney function while taking this drug. Dizziness, drowsiness, or other symptoms may occur while taking this medication, so caution should be taken when driving or operating hazardous machinery. Interactions may occur when combined with specific medications, so if you are taking other medications, be sure to inform your healthcare provider. This drug contains sorbitol; therefore, patients who cannot metabolize fructose due to a genetic condition are advised not to take it. Elderly patients may respond more sensitively to this drug; it is safer to start at a lower dose and gradually increase it. In case of overdose, serious hypotension and heart problems may occur, so it is essential to adhere to the prescribed dose and consult with healthcare providers immediately if any unusual symptoms arise. The safety and efficacy of this drug in pediatric patients under 18 years of age have not been sufficiently established, so its use is not recommended. This medication should be stored out of reach of children in a safe place, and it is advisable to open the package right before consumption.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 97 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormality
  • liver damage
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • kidney function impairment
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated serum uric acid
  • increased blood creatinine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to light and should be stored in a special container that protects it from light. It is recommended to store the medication at room temperature, between 1°C and 30°C, in a place that is not too hot or too cold.

Appearance and packaging

Appearance

It is a white and light gray biconvex oval double tablet.

Package unit

30 tablets (10 tablets/PTP) × 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.